Your browser doesn't support javascript.
loading
I. Poloxamer-formulated plasmid DNA-based human cytomegalovirus vaccine: evaluation of plasmid DNA biodistribution/persistence and integration.
Vilalta, Adrián; Mahajan, Rohit K; Hartikka, Jukka; Rusalov, Denis; Martin, Terrie; Bozoukova, Vesselina; Leamy, Vicky; Hall, Keith; Lalor, Peggy; Rolland, Alain; Kaslow, David C.
Affiliation
  • Vilalta A; Vical Incorporated, San Diego, CA 92121, USA. avilalta@vical.com
Hum Gene Ther ; 16(10): 1143-50, 2005 Oct.
Article in En | MEDLINE | ID: mdl-16218775
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Viral Proteins / Vaccines, DNA / Poloxamer / Cytomegalovirus Vaccines / Cytomegalovirus Limits: Animals / Humans Language: En Journal: Hum Gene Ther Journal subject: GENETICA MEDICA / TERAPEUTICA Year: 2005 Document type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Viral Proteins / Vaccines, DNA / Poloxamer / Cytomegalovirus Vaccines / Cytomegalovirus Limits: Animals / Humans Language: En Journal: Hum Gene Ther Journal subject: GENETICA MEDICA / TERAPEUTICA Year: 2005 Document type: Article Affiliation country: United States